Forecast & Rating4 analysts currently cover Ironwood Pharma, of which 2 give a positive rating. The average price target is $6.35, about 61.2% upside from the current price of $3.94. Coverage is limited, so the data is for reference only. Data as of Jul 16, 2026; this does not constitute investment advice.
Jul 14, 2026
Price forecast
$6.3561.17%
Forecast & RatingBuy
4analysts
Strong buy25.00%
Buy25.00%
Hold50.00%
Sell0.00%
Strong sell0.00%
Strong buy
1
Buy
1
Hold
2
Sell
0
Strong sell
0
Target price forecast
Forecast baselineJul 26, 2026
Forecast met43.1%
Stock price$3.96
Average forecast price$6.4
Highest forecast price$11
Lowest forecast price$4
Average forecast price
$6.4
Highest forecast price
$11
Lowest forecast price
$4
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.